Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

The efficacy and safety of bevacizumab with modified irinotecan, leucovorin bolus, and 5-fluorouracil intravenous infusion (mIFL) in the first-line treatment of metastatic colorectal cancer (mCRC) has not been well evaluated in randomized clinical trials in Chinese patients. We conducted a phrase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Zhong-Zhen, Xu, Jian-Ming, Luo, Rong-Cheng, Feng, Feng-Yi, Wang, Li-Wei, Shen, Lin, Yu, Shi-Ying, Ba, Yi, Liang, Jun, Wang, Dong, Qin, Shu-Kui, Wang, Jie-Jun, He, Jing, Qi, Chuan, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012268/
https://www.ncbi.nlm.nih.gov/pubmed/21959045
http://dx.doi.org/10.5732/cjc.011.10188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012268/
https://www.ncbi.nlm.nih.gov/pubmed/21959045
http://dx.doi.org/10.5732/cjc.011.10188

Ejemplares similares